Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty

PRODUCT LITERATURE

Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty

Park KH - Personal Name;

Three-month gonadotropin-releasing hormone agonists (GnRHas) are expected to achieve better compliance in patients with central precocious puberty (CPP) compared to the monthly formulation. However, 1-month depot remains the dominant choice for conventional treatment worldwide. Our study aimed to investigate the long-term efficacy of a 3-month GnRHa for CPP treatment

Availability

Location name is not set Location name is not set

Pamorelin-009

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Pamorelin
Gonadotropin-releasing hormone
Specific Detail Info: -
Statement of Responsibility: Ann Pediatr Endocrinol Metab. 2024 Jun;29(3):161-166

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment